High prevalence of persistent COVID-19-related health anxiety and social restriction in patients with haematological disorders
- PMID: 37408108
- DOI: 10.1111/bjh.18960
High prevalence of persistent COVID-19-related health anxiety and social restriction in patients with haematological disorders
References
REFERENCES
-
- Willan J, Hernandez L, Katz H, Gray N, Bienz N. Post-COVID-19 syndrome in patients with haematological disorders who have survived infection with severe acute respiratory syndrome coronavirus-2. Br J Haematol. 2022;197:e19-23. https://doi.org/10.1111/bjh.18010
-
- Wood WA, Neuberg DS, Thompson JC, Tallman MS, Sekeres MA, Sehn LH, et al. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH research collaborative data hub. Blood Adv. Washington: ASH publications; Volume 4; 2020. p. 5966-75.
-
- Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399:1303-12.
-
- Shaw B, Shortt J, Low M, Rogers B, Kaplan Z, Fedele P, et al. Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2. Intern Med J. 2022;52:2172-5. https://doi.org/10.1111/imj.15954
-
- Willan J, Agarwal G, Bienz N. Mortality and burden of post-COVID-19 syndrome have reduced with time across SARS-CoV-2 variants in haematology patients. Br J Haematol. 2023;201:640-4. https://doi.org/10.1111/bjh.18700
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical